Novartis AG v. HEC Pharm Co. Ltd.
1:15-cv-00151
Overview
Parties
Defendant
HEC Pharm USA Inc. Operating Company
Represented By
4 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
HEC Pharm Co. Ltd. Operating Company
Represented By
7 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Mitsubishi Tanabe Pharma Corporation NPE (University / Research)
Represented By
4 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Novartis AG Operating Company
Represented By
13 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Novartis Pharmaceuticals Corporation Operating Company
Represented By
5 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Plaintiff
Mitsui Sugar Co. Ltd. NPE (University / Research)
Represented By
4 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Counter Claimant
HEC Pharm Group Operating Company
Represented By
4 Attorneys ListedStamoulis & Weinblatt LLC
Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 5,604,229 Asserted | Asserted Patent | View Official Patent → |
| 🇺🇸 United States | US 5,719,176 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 5,952,316 A | US Continuation / Sibling | View Official Patent → |
| 🇯🇵 Japan | JP 28328192 | Japan Counterpart | View Official Patent → |
| 🇯🇵 Japan | JP 17942793 | Japan Counterpart | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 1994008943 A1 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 47,883,495 A | US Continuation / Sibling | View Official Patent → |
Apotex, Inc. et al. v. Novartis AG et al.
TORRENT PHARMACEUTICALS LIMITED v. Novartis AG et al.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5604229
2-amino-1,3-propanediol compound and immunosuppressant
|
Filed: 1993-10-18
Issued: 1997-02-18
|
Expired (Term Ended)
+1949d PTA
Expires: 2019-02-18
|
|
|
US8324283
Solid pharmaceutical compositions comprising a SIP receptor agonist and a sugar alcohol
|
Filed: 2008-08-11
Issued: 2012-12-04
|
Expired (Term Ended)
Expires: 2026-03-29
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+1949 days) / Cellect Scrutiny — Over 1949 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
70
Dispositive
54
Granted
0
Denied
4
Pending / Review
56
Motions by Category
Key Dispositive Motions & Rulings